Your session is about to expire
← Back to Search
GlaucoCetin for Glaucoma
Study Summary
This trial is testing whether a daily medical food can improve the vision of glaucoma patients.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are currently using nitroglycerin medication.You have an eye condition that could make it difficult to accurately measure your eye pressure.You have a history of epilepsy or you currently take medicine for seizures.Your eyesight is good, with a vision of 20/40 or better in both eyes.You have had glaucoma surgery within the past 6 months.The liquid surrounding a sample is transparent.You are currently taking medications like clopidogrel or warfarin that prevent blood from clotting.You are not willing to take either the supplement or a fake pill (placebo) for a period of 6 months.You have had an eye injury in the past.You have used biotin, Ginkgo Biloba, or Citicoline in the past 3 months, or any other products containing Glaucocetin in the past 1 month.You have a known disorder that causes bleeding problems.Your high blood pressure or diabetes is not well controlled.You had surgery to remove a cataract from your eye in the last 3 months.You have had a laser eye procedure called selective laser trabeculoplasty in the past 3 months.
- Group 1: GlaucoCetin Peripheral Group
- Group 2: Placebo Peripheral Group
- Group 3: GlaucoCetin Central Group
- Group 4: Placebo Central Group
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this testing opportunity still accepting participants?
"Affirmative. According to the records available on clinicaltrials.gov, recruitment for this medical investigation is still happening. It was first announced February 1st 2021 and most recently updated June 30th 2022 with the aim of enrolling a hundred patients across one site."
How can I become involved in this clinical experiment?
"This medical trial requires 100 individuals between the ages of 40 and 80 who have been diagnosed with open-angle glaucoma. Additionally, Group 1 must meet at least one Hodapp-Parrish-Anderson criterion for defect; Group 2 must demonstrate a paracentral point repeatedly depressed to p<1% on 24-2 testing. Moreover, both groups should possess bilateral open angle glaucoma that can be corroborated by visual field defects (MD between -4.00 to -10 dB). Lastly, all participants need to present with an acuity level of 20/40 or better in each eye."
Does the study include elderly candidates?
"The parameters for patient participation in this medical experiment stipulate that the youngest age eligible to enroll is 40, while the oldest participant must not exceed 80 years old."
What is the scope of this clinical trial's participant base?
"Affirmative. The official information from clinicaltrials.gov states that the study is actively recruiting individuals, and was first posted on February 1st 2021 with a most recent update recorded by June 30th 2022. This trial necessitates recruitment of 100 patients to just one site."
Share this study with friends
Copy Link
Messenger